Saturday 17 October 2026 Export PLSE’s income statement to Excel — free account

Pulse Biosciences, Inc

PLSE Healthcare Medical Instruments & Supplies

Pulse Biosciences, Inc’s revenue for fiscal 2025 (year ended December 2025) was $350,000.00, down 50.0% from fiscal 2022. In the quarter to June 2026, revenue grew 4,922.2%, EPS fell 28.6% and free cash flow fell 45.4%, each against the same quarter a year earlier. Insiders bought in the last twelve months.

44.27 1.32 −2.90%

Follow PLSE

Alert me

Market cap: $3.3B
P/E: 0.0×
Fwd P/E: −19.0×
Dividend yield: —
F-score: n/a
Altman Z: 31.41
Beneish M: n/a
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Older periods	Sep '25	Dec '25	Mar '26	Jun '26
P/E ratio Full definition →	+8 more quarters Free account	0.00	0.00	0.00	0.00
P/S ratio Full definition →		1,517.45	1,526.95	1,978.44	1,619.34
P/FCF ratio Full definition →		0.00	0.00	0.00	0.00
P/Operating CF Full definition →		(91.47)	(62.71)	(100.58)	(102.57)
P/B ratio Full definition →		12.87	11.47	22.14	19.29
Price to Tangible BV Full definition →		13.38	11.97	23.27	19.89
EV/Sales Full definition →		1,480.03	1,502.31	1,975.05	1,589.11
EV/EBITDA Full definition →		0.00	0.00	0.00	0.00
EV/Operating CF Full definition →		(23.98)	(16.82)	(26.55)	(30.82)
EV/FCF Full definition →		(23.85)	(16.72)	(26.41)	(30.68)
Quick Ratio Full definition →		9.82	10.22	6.99	9.27
Current Ratio Full definition →		10.02	10.53	7.26	9.63
Net Debt/EBITDA Full definition →		4.73	4.49	3.62	4.06
Debt/Assets Full definition →		0.00%	0.00%	0.00%	0.00%
Debt/Equity Full definition →		0.00	0.00	0.00	0.00
Asset Turnover Full definition →		0.01	0.01	0.01	0.01
Operating CF/Net income Full definition →		0.67	0.85	0.79	0.76
Capex/Depreciation Full definition →		(0.24)	(0.41)	(0.13)	(0.35)
Research and Development Expense of Revenue Full definition →		13,247.67%	4,139.02%	3,139.65%	3,911.52%
Selling, General and Administrative Expense of Revenue Full definition →		10,210.47%	2,776.52%	1,643.64%	1,948.62%
Intangible Assets out of Total Assets Full definition →		0.03	0.04	0.04	0.03
Share Based Compensation of Revenue Full definition →		6,531.40%	1,882.58%	476.81%	1,145.85%
Graham Net Nets Full definition →		0.07	0.08	0.04	0.05
Graham Number Full definition →		0.00	0.00	0.00	0.00
Earnings Yield Full definition →		(6.38%)	(7.87%)	(5.09%)	(4.26%)
Free Cash Flow Yield Full definition →		(4.09%)	(5.88%)	(3.78%)	(3.20%)
Revenue per Share Full definition →		0.00	0.00	0.01	0.01
Operating CF per Share Full definition →		(0.19)	(0.22)	(0.21)	(0.27)
Capex per Share Full definition →		0.00	0.00	0.00	0.00
Free Cash Flow per Share Full definition →		(0.19)	(0.22)	(0.22)	(0.27)
Cash per Share Full definition →		1.41	1.20	1.00	1.47
Shareholders Equity per Share Full definition →		1.38	1.20	0.98	1.44
Interest Debt per Share Full definition →		0.00	0.00	0.00	0.00
Book value per Share Full definition →		1.38	1.20	0.98	1.44
Free Cash Flow Full definition →		(13.10)	(14.86)	(14.63)	(18.80)
Working Capital Full definition →		87.46	75.50	61.33	94.72
Capital Expenditures Full definition →		(0.06)	(0.10)	(0.03)	(0.09)
Net Current Asset Value Full definition →		81.09	69.54	55.81	89.64
EV/EBIT Full definition →		0.00	0.00	0.00	0.00
Capex to Sales Full definition →		0.72	0.40	0.08	0.21
Price to Operating Income Full definition →		0.00	0.00	0.00	0.00
Other line items
Average Receivables Full definition →		0.04	0.15	0.08	0.06
Average Payables Full definition →		2.35	2.23	2.57	2.79
Average Inventory Full definition →		3.96	0.44	0.12	0.14
Average Assets Full definition →		100.91	113.50	107.50	117.91
Average Common Equity Full definition →		85.91	97.76	92.38	101.99

Fold the line items

Columns are period end dates

Stockrow Weekly